Agile Therapeutics Inc (AGRX)
0.3755
0.00 (0.00%)
USD |
OTCM |
May 10, 15:54
Agile Therapeutics Cash from Operations (TTM): -9.577M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -9.577M |
September 30, 2023 | -11.31M |
June 30, 2023 | -28.38M |
March 31, 2023 | -22.79M |
December 31, 2022 | -35.95M |
September 30, 2022 | -51.01M |
June 30, 2022 | -52.88M |
March 31, 2022 | -65.28M |
December 31, 2021 | -65.20M |
September 30, 2021 | -81.25M |
June 30, 2021 | -62.67M |
March 31, 2021 | -54.10M |
December 31, 2020 | -47.31M |
September 30, 2020 | -17.92M |
June 30, 2020 | -23.00M |
March 31, 2020 | -18.61M |
December 31, 2019 | -15.69M |
September 30, 2019 | -15.56M |
June 30, 2019 | -14.33M |
March 31, 2019 | -16.14M |
December 31, 2018 | -16.90M |
Date | Value |
---|---|
September 30, 2018 | -19.57M |
June 30, 2018 | -22.55M |
March 31, 2018 | -24.27M |
December 31, 2017 | -24.56M |
September 30, 2017 | -21.67M |
June 30, 2017 | -22.22M |
March 31, 2017 | -22.57M |
December 31, 2016 | -23.30M |
September 30, 2016 | -25.45M |
June 30, 2016 | -25.28M |
March 31, 2016 | -26.57M |
December 31, 2015 | -25.48M |
September 30, 2015 | -25.92M |
June 30, 2015 | -26.48M |
March 31, 2015 | -21.08M |
December 31, 2014 | -14.50M |
September 30, 2014 | -10.83M |
June 30, 2014 | -7.044M |
March 31, 2014 | -7.862M |
December 31, 2013 | -13.02M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-81.25M
Minimum
Sep 2021
-9.577M
Maximum
Dec 2023
-36.46M
Average
-28.38M
Median
Jun 2023
Cash from Operations (TTM) Benchmarks
Altimmune Inc | -75.81M |
iBio Inc | -18.89M |
Verastem Inc | -86.46M |
Oragenics Inc | -7.291M |
Actinium Pharmaceuticals Inc | -39.63M |